Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

Authors :: Yuka Yamashita
Grazia Fazio
Hélène Cavé
Sabine Strehl
Kentaro Ohki
Judith M. Boer
Renate Kirschner-Schwabe
Agata Pastorczak
Eva Froňková
Joelle Tchinda
Markéta Žaliová
Marleen Bakkus
Monique L. den Boer
Cristina Leschi
Christine J. Harrison
Lucy Chilton
Stefanie Groeneveld-Krentz
Renate Panzer-Grümayer
Anthony V. Moorman
Wojciech Młynarski
Martin Stanulla
Giovanni Cazzaniga
Andishe Attarbaschi
Maria S. Pombo-de-Oliveira
Thayana Conceição Barbosa
Rosemary Sutton
Jan Trka
Gisela Barbany
Karin Nebral
Claire Schwab
Toshihiko Imamura
Roland P. Kuiper
Esmé Waanders
Ingegerd Ivanov Öfverholm
University of Zurich
Clinical Biology
Hematology
Pediatrics
Schwab, C
Nebral, K
Chilton, L
Leschi, C
Waanders, E
Boer, J
Žaliová, M
Sutton, R
Öfverholm, I
Ohki, K
Yamashita, Y
Groeneveld-Krentz, S
Froňková, E
Bakkus, M
Tchinda, J
Barbosa, T
Fazio, G
Mlynarski, W
Pastorczak, A
Cazzaniga, G
Pombo-de-Oliveira, M
Trka, J
Kirschner-Schwabe, R
Imamura, T
Barbany, G
Stanulla, M
Attarbaschi, A
Panzer-Grümayer, R
Kuiper, R
den Boer, M
Cavé, H
Moorman, A
Harrison, C
Strehl, S
Source :: Blood advances, 1(19), 1473-1477. American Society of Hematology
Publication Year :: 2017
Abstract: Key Points Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.

Tools